Showing results (61-70 of 751) with videos related to
Sort By:
Pageof 76
Gynecologic Oncology|January 10, 2022
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based reviewS M Temkin, E Chapman-Davis, N Nair, et al.Gynecologic Oncology|July 1, 1999
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumorsM R Brown, R Chuaqui, C D Vocke, et al.Biochemical and Biophysical Research Communications|June 8, 2002
E-selectin modulates the malignant properties of T84 colon carcinoma cellsA M Flugy, M D'Amato, D Russo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2019
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancerJ F Liu, W T Barry, M Birrer, et al.Journal of Pharmacokinetics and Biopharmaceutics|September 15, 1999
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parametersK S Bauer, E C Kohn, R M Lush, et al.Cancer Research|December 16, 1998
An improved method for construction of directionally cloned cDNA libraries from microdissected cellsL A Peterson, M R Brown, A J Carlisle, et al.Blood|March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapyC J Link, A Bicher, E C Kohn, et al.Biochemical and Biophysical Research Communications|June 30, 1988
Insulin-like growth factors stimulate chemotaxis in human melanoma cellsM L Stracke, E C Kohn, S A Aznavoorian, et al.The Journal of Biological Chemistry|May 5, 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cellsC P Minniti, E C Kohn, J H Grubb, et al.Cancer|November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerJ D Shapiro, M L Rothenberg, G A Sarosy, et al.Pageof 76